NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

HOLISTA COLLTECH LIMITED (HCT)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

Our website ranking of HCT: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare Perth
Level 17, 221 St Georges Terrace, Perth WA 6000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000HCT4
Address: 283 Rokeby Road Subiaco WA 6008
Tel:  02 8072 1400Fax: 02 8072 1440

Date first listed: 26/02/2004
Company Secretary: Jay Stephenson
Sector: Household & Personal Products Industry Group: XSJ
Activities: Bio-industrial company committed to the development and commercialisation of ovine collagen for cosmetic and biomedical applications

News & Events

Expand this box to read and print

The suspension of trading in the securities of Holista Colltech Limited will be lifted immediately, following the release by HCT of an announcement regarding an update to its "˜Collagen Market Update'.

26/05/2021

The company provides additional information at the request of the ASX to the announcement released on 13 May 2021 entitled "Collagen Market Update".

26/05/2021

The company would like to request for a further extension of the voluntary suspension be effective from 25 May 2021 until the earlier of the commencement of normal trading on Thursday 27 th May 2021 or the release of the announcement.

25/05/2021

The company would like to request for a further extension of the voluntary suspension be effective from 24 May 2021 until the earlier of the commencement of normal trading on Tuesday 25th May 2021 or the release of the announcement to provide further information on the announcement previously made on 13 May 2021 titled 'Collagen Market Update'.

24/05/2021

The company requests a further extension of the volulntary suspension of its securities until the earlier of the commencement of normal trading on Monday 24th May 2021 or the release of the announcement to provide further information on the announcement previously made on 13 May 2021 titled Collagen Market Update.

20/05/2021

The securities of Holista Colltech Limited will be suspended from the commencement of quotation on Tuesday, 18 May 2021, under Listing Rule 17.2, at the request of HCT, pending the release of an announcement regarding an update to its "˜Collagen Market Update'.

17/05/2021

The suspension of trading in the securities of Holista CollTech Limited will be lifted immediately following the release by HCT of an announcement regarding the M3 system.

11/12/2020

Holista is authorised to immediately offer a "List N" certified solution to disinfect buildings amid a second wave of COVID-19 infections. Laboratoire M2 to supply its List N disinfectant, Bioesque, for use in the M3 system while Path Away is in the process of being registered on List N. Bioesque is a botanical 100% natural disinfectant similar to Path-Away. Products on List N meet U.S. EPA's criteria for use against SARS-CoV-2, which causes COVID-19. GICC has tested and certified Bioesque as the only alternative disinfectant to Path-Away that can be used in the M3 system.

11/12/2020

The securities of Holista CollTech Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of HCT, pending the release of an announcement regarding the M3® system.

10/12/2020

The suspension of trading in the securities of Holista CollTech Limited will be lifted immediately, following the release by HCT of an announcement regarding a subsidiary and strategic partnership.

14/09/2020

Holista Sets Up North American operations and ends exclusive distribution agreement with Health Therapies LLC. Holista secures new partnership with Eight Mercatus USA, which is led by Mr Poonacha Machaiah. Mr Machaiah is the current CEO of The Chopra Foundation with long experience in the wellness space. Eight Mercatus Pte Ltd and Eight Mercatus (USA) Pte Ltd will be Holista's strategic business and marketing partners for the North America markets.

14/09/2020

The company issues a notice of Proposed issue of Securities - HCT.

14/09/2020

The securities of Holista CollTech Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of HCT, pending the release of an announcement regarding a subsidiary and strategic partnership.

14/09/2020

securities reinstated

08/11/2011

securities suspended pending an announcement

07/11/2011

name changed from Colltech Australia Limited

28/07/2009

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.
Loading comments....  Most recent comments

re hct   -  what is its  SRN number  ?

conran22 @hotmail.com

04/06/2018 09:51:39

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    31/01/2019Rajen Marnickavasagar340,000$0.054$18,445
    26/07/2012Warren Staude20,750$0.078$1,612

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    David DeloubNon Exec Chairman06/04/2023
    Loren KingNon Exec Director31/07/2021
    Rajen MarnickavasagarDirector, CEO10/07/2009

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Walter JosephNon Exec Director28/06/202106/04/2023
    Daniel O'ConnorNon Exec Chairman29/11/201131/07/2021
    Blair MichelsonNon Exec Director11/08/202028/06/2021
    Chan Heng FaiNon Exec Director01/07/201328/06/2021
    Jonathan PagerDirector02/07/202011/08/2020
    Brett FraserNon Exec Chairman21/02/202002/07/2020
    Mark CollinsNon Exec Chairman, Non Exec Director01/08/201231/07/2013
    Warren StaudeNon Exec Director01/02/201203/10/2012
    Stuart HazellNon Exec Director14/10/201001/02/2012
    Fathil MohamedNon Exec Director15/05/200801/12/2011
    Paul RengelNon Exec Director02/10/2011
    Mick AwNon Exec Director07/08/200903/04/2011
    Michael PixleyNon Exec Director28/09/200625/11/2010
    Ravindran GovindanNon Exec Director30/05/200825/11/2010
    Stephen CarterNon Exec Director31/12/200513/11/2009
    Gregg MastroianniNon Exec Director12/04/200701/06/2008
    Anna KluczewskaNon Exec Director06/08/200323/11/2007
    John SnowdenExecutive Director17/12/200230/11/2006
    Michael BlakistonChairman27/11/200325/12/2005

    Date of first appointment, title may have changed.